BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23932785)

  • 1. Infliximab versus azathioprine to prevent postoperative recurrence in Crohn's disease: are all controversial issues defined?
    Kotze PG; Yamamoto T
    J Crohns Colitis; 2013 Dec; 7(12):e698. PubMed ID: 23932785
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of postoperative recurrence with azathioprine or infliximab in patients with Crohn's disease: an open-label pilot study.
    Armuzzi A; Felice C; Papa A; Marzo M; Pugliese D; Andrisani G; Federico F; De Vitis I; Rapaccini GL; Guidi L
    J Crohns Colitis; 2013 Dec; 7(12):e623-9. PubMed ID: 23810678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reply to Dr. Kotze's and Dr. Yamamoto's letter.
    Armuzzi A; Felice C
    J Crohns Colitis; 2013 Dec; 7(12):e699. PubMed ID: 23972685
    [No Abstract]   [Full Text] [Related]  

  • 4. Infliximab for postsurgical endoscopic recurrence of Crohn's disease: no trumpets yet.
    Sorrentino D; Paviotti A
    Inflamm Bowel Dis; 2009 Oct; 15(10):1458-9. PubMed ID: 19462431
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
    Ford AC
    Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
    Reinisch W; Stange EF;
    Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886
    [No Abstract]   [Full Text] [Related]  

  • 7. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
    Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
    J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot study.
    Papamichael K; Archavlis E; Lariou C; Mantzaris GJ
    J Crohns Colitis; 2012 Oct; 6(9):924-31. PubMed ID: 22424843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for the prevention of postoperative recurrence of Crohn's disease.
    Yamamoto T; Watanabe T
    Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary biliary cirrhosis developing in a patient with Crohn's disease during the course of infliximab treatment: the first case in the literature.
    Sisman G; Erzin Y; Bal K
    J Crohns Colitis; 2013 Oct; 7(9):e397-8. PubMed ID: 23583098
    [No Abstract]   [Full Text] [Related]  

  • 11. Infliximab, azathioprine, or combination therapy for Crohn's disease.
    Gelber AC
    N Engl J Med; 2010 Sep; 363(11):1086; author reply 1087-8. PubMed ID: 20848680
    [No Abstract]   [Full Text] [Related]  

  • 12. Longstanding Crohn's vulvitis successfully treated with combined anti-TNFα antibody and azathioprine.
    Macdonagh E; Pugh S; Fox R
    J Obstet Gynaecol; 2013 Jul; 33(5):530. PubMed ID: 23815219
    [No Abstract]   [Full Text] [Related]  

  • 13. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
    González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
    J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
    [No Abstract]   [Full Text] [Related]  

  • 14. [Crohn's disease: no advantage by azathioprine and 6-mercaptopurine].
    Schreiber S
    Dtsch Med Wochenschr; 2013 Sep; 138(38):1877. PubMed ID: 24022448
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of postoperative recurrence of Crohn's disease.
    van Loo ES; Dijkstra G; Ploeg RJ; Nieuwenhuijs VB
    J Crohns Colitis; 2012 Jul; 6(6):637-46. PubMed ID: 22398096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study.
    Yamamoto T; Umegae S; Matsumoto K
    Inflamm Bowel Dis; 2009 Oct; 15(10):1460-6. PubMed ID: 19266566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab, azathioprine, or combination therapy for Crohn's disease.
    Herrlinger KR; Stange EF
    N Engl J Med; 2010 Sep; 363(11):1086; author reply 1087-8. PubMed ID: 20825325
    [No Abstract]   [Full Text] [Related]  

  • 18. Infliximab, azathioprine, or combination therapy for Crohn's disease.
    Ruffolo C; Scarpa M; Bassi N
    N Engl J Med; 2010 Sep; 363(11):1086-7; author reply 1087-8. PubMed ID: 20848681
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug therapy of Crohn disease].
    Niemelä S
    Duodecim; 2001; 117(8):807-14. PubMed ID: 12116446
    [No Abstract]   [Full Text] [Related]  

  • 20. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
    Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR;
    Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.